Presentation is loading. Please wait.

Presentation is loading. Please wait.

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled.

Similar presentations


Presentation on theme: "Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled."— Presentation transcript:

1 Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials  Jennifer L. Jones, Gilaad G. Kaplan, Laurent Peyrin-Biroulet, Leonard Baidoo, Shane Devlin, Gil Y. Melmed, Divine Tanyingoh, Laura Raffals, Peter Irving, Patricia Kozuch, Miles Sparrow, Fernando Velayos, Brian Bressler, Adam Cheifetz, Jean-Frederic Colombel, Corey A. Siegel  Clinical Gastroenterology and Hepatology  Volume 13, Issue 13, Pages e2 (December 2015) DOI: /j.cgh Copyright © 2015 AGA Institute Terms and Conditions

2 Figure 1 Flow diagram of included studies.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh ) Copyright © 2015 AGA Institute Terms and Conditions

3 Figure 2 Forest plot for pooled summary estimate for 6-month clinical remission. M-H, Mantel-Haenszel. Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh ) Copyright © 2015 AGA Institute Terms and Conditions

4 Figure 3 Forest plots displaying results for subgroup analysis of 6-month clinical remission by anti-TNF agent. M-H, Mantel-Haenszel. Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh ) Copyright © 2015 AGA Institute Terms and Conditions


Download ppt "Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled."

Similar presentations


Ads by Google